For the malaria vaccine, what was the additional 2$ cost for? In the citation, it just says it is an assumed constant. Why is it per child and not per dose?
The additional $2 cost appears to be an amortization of various administration, implementation, and monitoring costs.
but are there specific cost-related factors that you predict matter more or less? Does making a vaccine that does not require refrigeration lower the cost substantially in rollout?
We haven’t looked into this in detail so it’s hard to say. Making a vaccine that does not require refrigeration would cut down on costs related to maintaining and creating a “cold chain” (continuous refrigerated storage and transportation), but I don’t anticipate these costs being that high and I’d expect them to be offset by significantly increased manufacturing costs per dose for making such a vaccine.
We’ll have more conclusions on cost and cost effectiveness in future posts.
The additional $2 cost appears to be an amortization of various administration, implementation, and monitoring costs.
We haven’t looked into this in detail so it’s hard to say. Making a vaccine that does not require refrigeration would cut down on costs related to maintaining and creating a “cold chain” (continuous refrigerated storage and transportation), but I don’t anticipate these costs being that high and I’d expect them to be offset by significantly increased manufacturing costs per dose for making such a vaccine.
We’ll have more conclusions on cost and cost effectiveness in future posts.